Virtual 3D models of the body and individual organs will allow us to test drugs and procedures faster than ever before with no harm to patients or animals.
Clinical trials (i.e. testing a drug in humans) can take years to perform - going through phase 1 (checking for safety), phase 2 (checking for efficacy and side-effects) and phase 3 (monitoring adverse reactions). Less than one in ten successfully make it to market. That's a lot of wasted time and effort.
Digital modelling allows testing from a cellular level to whole body interactions to take place in silico - in software. As the digital models improve, and the speed of computers continue to increase, rather than taking months to perform a phase 1 trial this may be carried out in a few days on a supercomputer. Even if not 100% accurate to start with, it should at least increase the success rate of drug development.
Tap on icon for description, click on resource name for more details.
Patient-specific heart simulation for optimal therapy and In silico evaluation of cardiotoxicity and drug discovery company
Digital Modeling Blog Posts
Technology to create virtual tumours and treat them with AI-designed nanoparticles
Nano Magazine - 22-Sep-2021
Virtual cancer tumours can be grown and we can design personalised nanoparticles to treat themRead more...
Study on the accuracy of in-silico trials as compared to traditional trials
Medgadget - 24-Jun-2021
Virtual clinical trial can reduce the cost and time required while reducing riskRead more...
Detailed map of connections within the human brain created by Google
New Scientist - 07-Jun-2021
Benefit to explore how the cell map differs in people with mental illnessRead more...
Aging clock predicting the effect of longevity interventions
Lifespan.io (LEAF) - 03-Jun-2021
Transcriptomic aging clock: providing insight into the changes involved in agingRead more...
Building digital twins for effective & personalized medicine
Science - 12-Mar-2021
Computer models to predict disease prognosis, health care needs, and fight future pandemicsRead more...